This fact sheet details our comprehensive approach to CNS drug development, highlighting our expertise in neurology, psychiatry, neuropathic pain and rare diseases. Our CNS teams have extensive experience and strong knowledge of the challenges expected when implementing CNS clinical trials and how to mitigate them. Comprehending the specifics of each therapeutic area requires a large spectrum of expertise that IQVIA Biotech can offer to biotech companies. We emphasize our global relationships, operational expertise and commitment to accelerating innovative therapies to patients faster.

Download the fact sheet to discover how our dedicated CNS team can support you in overcoming every hurdle.